C. Peña

发表论文 91 篇 · 总被引 5512 次 · h-index 26

代表论文

• Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma. (2017 · Journal of Clinical Oncology · 被引 351)
• Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial (2018 · Gut · 被引 290)
• Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors (2022 · JCO Precision Oncology · 被引 68)
• Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors (2021 · Clinical Cancer Research · 被引 57)
• Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma (2020 · Leukemia · 被引 57)
• Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer (2020 · Targeted oncology · 被引 45)